Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
企業コードALC
会社名Alcon AG
上場日Apr 09, 2019
設立日2018
最高経営責任者「CEO」Mr. David J. Endicott
従業員数25599
証券種類Ordinary Share
決算期末Apr 09
本社所在地Rue Louis d'Affry 6
都市FRIBOURG
証券取引所SIX Swiss Exchange
国Switzerland
郵便番号1700
電話番号41589113800
ウェブサイトhttps://www.alcon.ch/
企業コードALC
上場日Apr 09, 2019
設立日2018
過去5年間の配当金総支払額は
400.00M
米ドルである。
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021